EurekaMag
+ Translate
+ Most Popular
Cunninghamia lanceolata plantations in China
Mammalian lairs in paleo ecological studies and palynology
Studies on technological possibilities in utilization of anhydrous milk fat for production of recombined butter-like products
Should right-sided fibroelastomas be operated upon?
Large esophageal lipoma
Apoptosis in the mammalian thymus during normal histogenesis and under various in vitro and in vivo experimental conditions
Poissons characoides nouveaux ou non signales de l'Ilha do Bananal, Bresil
Desensitizing efficacy of Colgate Sensitive Maximum Strength and Fresh Mint Sensodyne dentifrices
Administration of fluid by subcutaneous infusion: revival of a forgotten method
Tundra mosquito control - an impossible dream?
Schizophrenia for primary care providers: how to contribute to the care of a vulnerable patient population
Geochemical pattern analysis; method of describing the Southeastern limestone regional aquifer system
Incidence of low birth weights in a hospital of Mexico City
Tabanidae
Graded management intensity of grassland systems for enhancing floristic diversity
Microbiology and biochemistry of cheese and fermented milk
The ember tetra: a new pygmy characid tetra from the Rio das Mortes, Brazil, Hyphessobrycon amandae sp. n. (Pisces, Characoidei)
Risk factors of contrast-induced nephropathy in patients after coronary artery intervention
Renovation of onsite domestic wastewater in a poorly drained soil
Observations of the propagation velocity and formation mechanism of burst fractures caused by gunshot
Systolic blood pressure in a population of infants in the first year of life: the Brompton study
Haematological studies in rats fed with metanil yellow
Studies on pasteurellosis. I. A new species of Pasteurella encountered in chronic fowl cholera
Dormancy breaking and germination of Acacia salicina Lindl. seeds
therapy of lupus nephritis. a two-year prospective study

Neoadjuvant chemotherapy for advanced ovarian cancer: overview of outcomes and unanswered questions


Neoadjuvant chemotherapy for advanced ovarian cancer: overview of outcomes and unanswered questions



Expert Review of Anticancer Therapy 11(7): 1053-1067



ISSN/ISBN: 1473-7140

PMID: 21806329

DOI: 10.1586/era.11.24

Neoadjuvant chemotherapy for advanced ovarian cancer was initially administered as an alternative treatment for patients not suitable for primary debulking surgery (PDS) because of unresectable tumor or poor performance status. Accumulation of favorable outcomes of this treatment compared with standard treatment starting with PDS made this strategy a candidate for prospective, randomized Phase III studies without limiting the subjects to patients who were unsuitable for PDS. Among the four Phase III studies to date, the earliest study from the European Organization for Research and Treatment of Cancer (EORTC) has revealed noninferior survival with less-serious morbidity in the neoadjuvant chemotherapy arm. These data suggest that neoadjuvant chemotherapy followed by surgical cytoreduction is an acceptable management strategy for patients with advanced ovarian cancer. In this article, we review the treatment outcomes and discuss some unanswered questions, as well as possible future research in this area.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 054566903

Download citation: RISBibTeXText

Related references

Clinical Trials of Hyperthermic Intraperitoneal Chemotherapy in Advanced Ovarian Cancer: Unanswered Questions. Oncology 29(9): 702-704, 2015

Outcomes of advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy. Indian Journal of Cancer 55(1): 50-54, 2018

Comparison of clinical outcomes in women with advanced ovarian cancer undergoing neoadjuvant chemotherapy who receive threevs greater than three cycles of chemotherapy after interval cytoreductive surgery. Gynecologic Oncology 145: 71-72, 2017

Survival outcomes after delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 30(12): 1935-1942, 2020

Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: utility of a scoring system to predict outcomes. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 29(6): 1064-1071, 2019

Serum CA 125 Level after Neoadjuvant Chemotherapy is Predictive of Prognosis and Debulking Surgery Outcomes in Advanced Epithelial Ovarian Cancer. Journal of Nippon Medical School 84(4): 170-176, 2017

Outcomes of Non-High Grade Serous Carcinoma after Neoadjuvant Chemotherapy for Advanced-Stage Ovarian Cancer: Single-Institution Experience. Yonsei Medical Journal 59(8): 930-936, 2018

A Comparison of Survival Outcomes in Advanced Serous Ovarian Cancer Patients Treated With Primary Debulking Surgery Versus Neoadjuvant Chemotherapy. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 27(4): 668-674, 2017

A Comparison of Survival Outcomes in Advanced Serous Ovarian Cancer Patients Treated With Primary Debulking Surgery Versus Neoadjuvant Chemotherapy. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 27(4): 668-674, 2017

Peritoneal tuberculosis simulating advanced ovarian carcinoma: is clinical impression sufficient to administer neoadjuvant chemotherapy for advanced ovarian cancer?. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 16(Suppl): 307-312, 2006

Upper abdominal cytoreduction and thoracoscopy for advanced epithelial ovarian cancer: unanswered questions and the impact on treatment. Bjog: An International Journal of Obstetrics and Gynaecology 119(2): 202-206, 2012

Outcomes of non-high grade serous carcinoma after neoadjuvant chemotherapy for advanced-stage ovarian cancer: a Korean gynecologic oncology group study (OV 1708). Bmc Cancer 19(1): 341, 2019

Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group. Bmj 303(6807): 884-893, 1991

Neoadjuvant chemotherapy prior to intraperitoneal chemotherapy in women with advanced ovarian cancer. Community Oncology 5(7): 376-380, 2008

Is Neoadjuvant Chemotherapy Feasible Prior to Intraperitoneal Chemotherapy in Women with Advanced Ovarian Cancer?. Gynecologic Oncology 107(2): 366-366, 2007